Skip to main content

Advertisement

Figure 1 | BMC Genomics

Figure 1

From: Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

Figure 1

Overview of the analysis design. (a) First part of the analysis including quality controls, normalization, preliminary clustering performed on the untreated dataset, computation of the cluster centroids on the tamoxifen treated dataset, and estimation of signature stability with regards to signature size, using cross-validation. (b) Second part of the analysis including the classifier development, performance assessment by cross-validation and performance assessment on independent validation data sets.

Back to article page